46 results
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
was also an important step in bringing our high impact medicines to the rare disease patient community. We look forward to continuing this momentum
S-3ASR
vgwu z6r9nslcy
13 Oct 23
Automatic shelf registration
4:47pm
8-K
EX-99.1
q4aa3us2v1
13 Oct 23
Other Events
4:16pm
8-K
EX-99.1
adv0dgx0nwb34
5 Sep 23
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
8:36am
8-K
EX-99.1
a147hbisa0wolp6cwh14
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
iraoxpho
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
tci7iim7hebed6
24 Oct 22
Regulation FD Disclosure
8:46am
8-K
EX-99.1
u3dma7ubq
9 Mar 22
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
4:05pm